Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW.
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S118-57. doi: 10.1002/acr.20532.
Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR.
Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7.
Dermatomyositis of childhood.
Lell ME, Swerdlow ML.
Pediatr Ann. 1977 Mar;6(3):203-12.
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC, Lam JM, Alobaida S, Leong KF, Wong AHC.
Curr Pediatr Rev. 2021;17(4):273-287. doi: 10.2174/1573396317666210426105045.
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
Feldman BM, Rider LG, Reed AM, Pachman LM.
Lancet. 2008 Jun 28;371(9631):2201-12. doi: 10.1016/S0140-6736(08)60955-1.
Erythroderma in the elderly.
Yamamoto T.
J Dermatol. 2025 Feb;52(2):221-227. doi: 10.1111/1346-8138.17538. Epub 2024 Nov 11.
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.
Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Giménez AI, Hinze C, McCann LJ, Reed AM, Rider LG, Arvigo M, Bader-Meunier B, Bruno C, Caifeng L, Campanilho-Marques R, Cuccato S, Fiorillo C, Hahn NA, Huber AM, Jansen M, Kasapcopur O, Katsikas MM, Kim S, Livermore P, Maillard S, Malattia C, Migowa AN, Miyamae T, Murphy R, Nicolai R, Papadopoulou C, Pilkington C, Sanner H, Sawhney S, Smolewska E, Tarvin SE, Tiller G, Toplak N, Wedderburn LR, Bovis F, Consolaro A, Feldman BM.
Ann Rheum Dis. 2025 Jul;84(7):1055-1067. doi: 10.1016/j.ard.2025.04.024. Epub 2025 May 22.
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.
Ramanan AV, Feldman BM.
Rheum Dis Clin North Am. 2002 Nov;28(4):833-57. doi: 10.1016/s0889-857x(02)00024-8.
The childhood type of dermatomyositis.
Carpenter S, Karpati G, Rothman S, Watters G.
Neurology. 1976 Oct;26(10):952-62. doi: 10.1212/wnl.26.10.952.
Childhood polymyositis/dermatomyositis.
Roberts LJ, Fink CW.
Clin Dermatol. 1988 Apr-Jun;6(2):36-46, 49-51. doi: 10.1016/0738-081x(88)90048-x.
